Cytomegalovirus Treatment Market: Global Industry Analysis, Size and Forecast, 2018 to 2028

Home
Market Research Reports
Healthcare, Pharmaceuticals and Medical devices
Cytomegalovirus Treatment Market

An Incisive, In-depth Analysis on the Cytomegalovirus Treatment Market

This study offers a comprehensive, 360 degree analysis on the Cytomegalovirus Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Cytomegalovirus Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample

Ask An Analyst

Request Special Price

Request Methodology

Combinational Antiviral Therapy Will Create More Opportunities for Cytomegalovirus Treatment

The most important and effective strategy in the prevention of cytomegalovirus infection is to avoid immunodeficiency as it increases the risk of infection and cytomegalovirus reactivation. The wide use of combinational antiviral therapy is decreasing the rate of HIV infection in people. Direct acting antiviral medicines coupled with the use of cART affects immune restoration and will give a push to the cytomegalovirus treatment market worldwide.

Growing Prevalence of Congenital CMV Infection

Congenital Cytomegalovirus disease transpires in approximately 1% of all live births. The bulk of the cases are asymptomatic, but almost 5–10% of infants with congenital CMV will have significant chances of disease. CMV infection in the neonate generates attenuated interferon response associated to a similar infection in the adult. Cytomegalovirus infection and risk of reactivation of cytomegalovirus infection have been reported during pregnancy. These can also lead to congenital CMV infection. Prediction for neonates with infection is poor, with a high possibility of mental deficits, hearing loss, prematurity, hepatosplenomegaly, jaundice. Morbidity & mortality are connected with congenital CMV infection, emphasizing the requirement for cytomegalovirus treatment and vaccine to inhibit CMV infection. Antiviral agents such as ganciclovir, valganciclovir reduce the risk hearing disorders. Ganciclovir and valganciclovir provide advances in cytomegalovirus treatment because of oral bioavailability, efficacy, and limitation of toxicity. There is a need for new drugs, as comparatively few research programs are currently focusing on anti-cytomegalovirus treatment.

CMV Retinitis among AIDS Patients to Drive Cytomegalovirus Treatment Market Growth

The cytomegalovirus treatment market is expected to witness lucrative growth due to increasing cases of CMV retinitis. Cytomegalovirus retinitis is a moderately rare exhibition of cytomegalovirus disease in other immunocompromised populations. It is the initial indication of cytomegalovirus infection in patients with AIDS. Up to 25% of patients with AIDS developed cytomegalovirus retinitis. Cytomegalovirus retinitis is a disease identified by necrotizing retinitis that can begin to cause retinal organization and blindness. Cytomegalovirus retinitis and other exhibitions of cytomegalovirus disease in individuals with HIV-1 infection are opportunistic infections, transpiring when CD4+ cell counts are extremely suppressed. High value-added active antiretroviral therapy will drive the growth of the cytomegalovirus treatment market. The growing demand for cytomegalovirus treatment, due to the increasing prevalence of cytomegalovirus retinitis in AIDS patients is the major factor fueling the cytomegalovirus treatment market across the globe.

Growing Awareness of Cytomegalovirus Treatment in Stem Cell Transplant

The rising prevalence and incidences of cytomegalovirus infections is a prime driver of the cytomegalovirus treatment market. The cytomegalovirus treatment market is mainly growing because of the rising prevalence rate of cytomegalovirus infection in different indications such as congenital CMV, cytomegalovirus retinitis, stem cell therapy. The growing awareness of herpes is also driving the cytomegalovirus treatment market. Increased educational programs about cytomegalovirus infection and cytomegalovirus treatment, by public health interventions and pediatric counseling, are needed for all pregnant women to prevent cytomegalovirus infections.

Competitive Landscape

The competition section of the report features profiles of key players operating in the cytomegalovirus treatment market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include Merck & Co. Inc, Mylan N.V., Chimerix, Inc., Thermo Fisher Scientific, Abbott, Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pfizer, and among others.

Mergers and acquisitions, product innovations, and partnerships are the some of the key strategies being adopted by the manufactures of to gain maximum share in the cytomegalovirus treatment market. Manufacturers are also planning to invest in new facilities to increase productivity.

Definition

Cytomegalovirus is a common virus of the herpes family which also includes the herpes simplex viruses and causes chickenpox and mononucleosis. Cytomegalovirus infects people of all ages and CMV is spread through body fluids such as blood, saliva, tears, breast milk, urine, semen, and vaginal fluids. Antiviral drug and combinational of antiviral therapy are used to treat cytomegalovirus infections.

About the Report

The company has conducted a research study on the cytomegalovirus treatment market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the cytomegalovirus treatment market. The report elaborates the macroeconomic factors influencing the dynamics in the cytomegalovirus treatment market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the cytomegalovirus treatment market based on drug type, application, and distribution channel. Based on drug type, the cytomegalovirus treatment market is segmented into ganciclovir, valganciclovir, foscarnet, cidofovir, and other. Based on application, the cytomegalovirus treatment market is segmented into stem cell transplantation, organ transplantation, congenital CMV infection, and others. Based on distribution channel, the cytomegalovirus treatment market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. The cytomegalovirus treatment market has been analyzed across regions of North America, Latin America, Western Europe, Eastern Europe and Asia Pacific Including Japan, China and MEA.

Additional Questions Answered

Some of the additional questions addressed in this report on the cytomegalovirus treatment market-

What is the revenue potential of the cytomegalovirus treatment market across regions of North America and Europe?
Who are the key competitors and what are their portfolios in the cytomegalovirus treatment market?
What are some of the major challenges influencing the growth of the cytomegalovirus treatment market?
How intervention from the regulatory authorities is shaping the cytomegalovirus treatment market growth?

Research Methodology

The cytomegalovirus treatment market has been estimated based on supply-demand approach. All the information has been further validated through rigorous primary research (including interviews, surveys, in-person interactions and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals and resourceful databases). The research study on the cytomegalovirus treatment market also includes top trends and macro as well as micro economic factors shaping the cytomegalovirus treatment market.

A recent market study published by the company – 'Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', consists of an inclusive assessment of the most important market dynamics on Cytomegalovirus with assessed medications. The company has done some direct research on the principle structure of the Cytomegalovirus treatment market. A direct market overview provides the growth scenarios and market potential with maximum precision, and adjudged with suitable assumptions. The report features unique and relevant factors that may have a huge impact on the development of the Cytomegalovirus treatment market during the forecast period. This report includes a detailed and considerable amount of inclusion, which would help new manufacturers with the most comprehensive way for better understanding

Chapter 1 – Executive Summary

The report commences with the executive summary of the Cytomegalovirus treatment market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) for leading segments in the Cytomegalovirus treatment market.

Chapter 2 – Market Introduction

Readers can find a detailed market structure and definition of Cytomegalovirus treatment and drug types, in this chapter, which helps in understanding the basic information about the Cytomegalovirus treatment market. The definition section considers the factors included and excluded for the purpose of this report.

Chapter 3 – Market Background

Readers can find the outlook of the global Cytomegalovirus treatment market, considering various factors associated with the growth, which would help in tracking the market’s current scenario, with key inferences drawn from historical data, current trends, and future prospects. Macro-economic factors influencing the market are also discussed in this segment. A brief understanding of the global healthcare sector is also provided in this section.

Chapter 4 – Market Dynamics

This chapter highlights the key market dynamics, including drivers, restraints, opportunities, and trends. In this chapter, readers can understand factors that are propelling the growth of the market, along with factors that may deter the growth of the market. Also, readers will understand the key trends followed by leading manufacturers in the Cytomegalovirus treatment market.

Chapter 5 – Cytomegalovirus Treatment Market: Key Inclusions

Key pointers such as pipeline drug analysis, reimbursement scenarios and new medical treatments for Cytomegalovirus are also included in this Cytomegalovirus treatment market report.

Chapter 6 – North America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth being observed in the North America Cytomegalovirus treatment market, along with country-wise assessment for the U.S. and Canada. Readers can also find information on regional trends, regulations and market growth based on Drug type, Application and Distribution channel and countries in North America.

Chapter 7 – Western Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

Important growth prospects of the Cytomegalovirus treatment market can be found with market attractiveness based on Drug type, Application and Distribution channel. European countries such as the U.K., Germany, France, Italy, Spain, Russia and Rest of Western Europe are included in this chapter for industry analysis.

Chapter 8 – Eastern Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Eastern Europe Cytomegalovirus treatment market, along with a country-wise assessment, including Russia, Poland and Rest of Eastern Europe. Market attractiveness based on various segments is provided for the Eastern European region.

Chapter 9 – Latin America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Latin America Cytomegalovirus treatment market, along with a country-wise assessment, including Brazil, Mexico and Rest of Latin America. Market attractiveness based on various segments is provided for the Latin American region

Chapter 10 – APEC Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

India, Australia & New Zealand, Japan and Rest of APAC are the leading countries/regions in the Asia Pacific region that are assessed to obtain the growth prospects of the APEC Cytomegalovirus treatment market in this chapter. Readers can find thorough information about the growth parameters. Market attractiveness based drug type, Application, and distribution channel for Cytomegalovirus treatment in the APEC region is also provided in this section.

Chapter 11 – China Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the China Cytomegalovirus treatment market. Market attractiveness based drug type, Application, and distribution channel is present for this region

Chapter 12 – MEA Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter provides information on how the Cytomegalovirus treatment market will grow in major countries of the MEA region, such as Saudi Africa, GCC Countries and Rest of MEA, during the period 2018-2028.

Chapter 13 – Forecast Factors: Relevance and Impact

This chapter provides forecast factors for relevance in building the market value for the Cytomegalovirus treatment market

Chapter 14 – Competitive Assessment

This chapter includes a comprehensive list of all the leading manufacturers in the Cytomegalovirus treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, and recent company developments. Market players featured in the report include Merck & Co. Inc, Mylan N.V., Chimerix, Inc., Thermo Fisher Scientific, Abbott, Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pfizer and among others

Chapter 15 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Region

This section highlights Cytomegalovirus treatment in the overall global market by value (US$ Mn) forecast and analysis, by region such as North America, Latin America, Western Europe, Eastern Europe and Asia Pacific Including Japan, China and MEA.

Chapter 16 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Drug Type

Based on drug type market analysis, the Cytomegalovirus treatment market is segmented into Ganciclovir, valganciclovir, Foscarnet, Cidofovir and other.

Chapter 17 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Application

Based on Application, the Cytomegalovirus treatment market is segmented into Stem Cell Transplantation, Organ Transplantation, Congenital CMV infection and others.

Chapter 18 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Distribution Channel

Based on distribution channel, the Cytomegalovirus treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-Commerce.

Chapter 19 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This section highlights the overall global market value (US$ Mn) forecast and analysis of the Cytomegalovirus treatment market, with detailed incremental opportunity and absolute opportunity.

Chapter 20 – Assumptions and Acronyms Used

This section consists of a glossary of the assumptions and acronyms used in the Cytomegalovirus treatment market report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the Cytomegalovirus treatment market.